The risk of violent crime committed by a person increases by almost 50 percent among people who take antipsychotic medication, such as clozapine or risperidone, a new study reveals.
The use of mood stabilising drugs (such as lithium or carbamazepine) is also associated with a reduced rate of violent crime, although the reduction is less pronounced, and only in patients with bipolar disorder.
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.
Advertisement
In this study, a team of researchers in the UK and Sweden, led by Dr Seena Fazel of Oxford University, UK, used Swedish national health registries to study the psychiatric diagnoses, and any subsequent criminal convictions, in over 80,000 patients (40,937 men and 41,710 women) who were prescribed antipsychotic or mood stabilising medication, from 2006 to 2009.
In the three years studied, 6.5 per cent (2657) of the men, and 1.4 per cent (604) of women were convicted of a violent crime. Compared with periods when participants were not on medication, violent crime fell by 45 per cent in patients receiving antipsychotics, and by 24 per cent in patients prescribed mood stabilisers.
![Senior Citizens Get Tech Savvy]( "Senior Citizens Get Tech Savvy")
By getting tech-savvy, senior citizens are fostering new engagements, bringing in positive change in their attitude, health, fighting depression and improving the quality of their lives.
Although the two types of medication are often combined, the researchers found no evidence that combining the drugs has any further effect on reducing violent crime, and for patients prescribed mood stabilisers, the medication was associated with reductions in violent crime only in male patients with bipolar disorder.
Moreover, although antipsychotic and mood stabilising medications are generally associated with treatment of schizophrenia or bipolar disorder, the researchers found that many people in the study were prescribed these drugs for other disorders, such as depression or alcohol and drug misuse.
The study has been published in The Lancet.
Source: ANI
Senior Citizens Get Tech Savvy
By getting tech-savvy, senior citizens are fostering new engagements, bringing in positive change in their attitude, health, fighting depression and improving the quality of their lives.
Advertisement
Although the two types of medication are often combined, the researchers found no evidence that combining the drugs has any further effect on reducing violent crime, and for patients prescribed mood stabilisers, the medication was associated with reductions in violent crime only in male patients with bipolar disorder.
Moreover, although antipsychotic and mood stabilising medications are generally associated with treatment of schizophrenia or bipolar disorder, the researchers found that many people in the study were prescribed these drugs for other disorders, such as depression or alcohol and drug misuse.
The study has been published in The Lancet.
Source: ANI
Holistic Management for Depression
Depression is a common disorder and many worldwide suffer from depression. Early recognition of symptoms and signs of depression can help in taking a holistic approach to the management of depression.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Promising test results on a substance offer hope for developing medications or vaccines against the increasing Zika virus cases in 2023.
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.